TRIM21 and interstitial lung disease: In contrast, several studies have indicated that patients with SjD, especially those with concomitant interstitial lung disease and anti-SSA antibody positivity, have a higher risk of VTE and PE, which may be related to reduced blood flow velocity and endothelial damage (15, 16).